Go to deals
Other Industries

Sihold NV has acquired Sioen Industries NV through a cash tender offer and delisting

Sihold NV has successfully completed a takeover bid. It was a voluntary and conditional takeover bid in cash and related to all shares issued by Sioen Industries. These shares were not held by Sihold NV, which already controlled the company. Sioen Industries was delisted from Euronext Brussels on 31 May 2021.

Sihold is the holding company of the Sioen family. Sioen Industries is a diversified group with an extensive portfolio of products and activities, namely the spinning, weaving and coating of technical textiles, manufacturing professional protective clothing and producing fine chemicals.

Oaklins’ team in Belgium acted as the exclusive buy-side advisor to Sihold NV in this transaction.

Parties

Talk to the deal team

Thomas Roelens

Managing Director
Brussels, Belgium
Oaklins KBC Securities

Tibo Steen

Associate Director
Brussels, Belgium
Oaklins KBC Securities

Amelie Arrazola de Onate

Senior Associate
Brussels, Belgium
Oaklins KBC Securities

Related deals

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
doValue has finalized a rights issue
Financial Services

doValue has finalized a rights issue

doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.

Learn more